second generation chitotriosidase 1 inhibitor (Molecure)

N/A

Report date: 2025/01/26 16:12:07
NME

Base Information

Drug Namesecond generation chitotriosidase 1 inhibitor (Molecure)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChitinase 1 inhibitors
TargetsChitinase 1
Therapy Area/IndicationsLung Diseases, InterstitialMetabolic Dysfunction-Associated Steatotic Liver DiseaseCentral Nervous System Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMolecure SA
China Registration ClassN/A

Develop Information

Active CompaniesMolecure SA
Inactive CompaniesN/A
Active IndicationsLung Diseases, InterstitialMetabolic Dysfunction-Associated Steatotic Liver DiseaseCentral Nervous System Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A